Clinical Trials Directory

Trials / Completed

CompletedNCT01321749

The Neuroprotective Effect of Remote Ischemic Preconditioning on Ischemic Cerebral Vascular Disease

Status
Completed
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
196 (actual)
Sponsor
Capital Medical University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

This study is a prospective, randomized, single-center trial, designed to observe the effect of remote limb ischemic preconditioning on ischemic cerebral vascular disease.

Conditions

Interventions

TypeNameDescription
PROCEDURERemote ischemic preconditioning (RIPC)The detail of RIPC included five cycles of bilateral upper limbs 5/5 min. of ischemia and reperfusion alternation. Limb ischemia was induced by inflating tourniquets to 200 mmHg. This process was placed on both arms every day.

Timeline

Start date
2008-01-01
Primary completion
2011-12-01
First posted
2011-03-24
Last updated
2012-04-25
Results posted
2012-04-25

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT01321749. Inclusion in this directory is not an endorsement.